|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression |
BEFREE |
Finally, Ku80 inhibits self-renewal and metastasis of hepatocellular carcinoma cells through breaking the SALL4-OCT4 interactions and down-regulating the expression of OCT4.
|
31816404 |
2020 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression |
BEFREE |
Additionally, OCT4-high expression was also strongly associated with higher clinical TNM stage, lymph node metastasis, tumor distant metastasis, higher histopathologic grade, but not related with gender, smoking status, tumor size and histologic type of lung cancer.
|
30854966 |
2019 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
<i>In vivo</i>, miR708-NP directly targeted the SOX2/OCT4-mCherry+ miR-708<sup>low</sup> tumor cells to impair metastasis.
|
30679387 |
2019 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
Egr1 exerts a promoting effect on cancer metastasis in Oct4-overexpressing lung cancer.
|
31399076 |
2019 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
More importantly, downregulation of β-catenin could effectively prevent its enrichment in nuclei and then significantly downregulate the expression of proteins, such as vimentin, Snail, MMP-2, MMP-9, CD44, Nanog, and Oct4 to prevent tumor progression and metastasis.
|
30540162 |
2019 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression |
BEFREE |
OCT4 mRNA was overexpressed in effusions compared to solid specimens (p = 0.046), whereas SOX9 was overexpressed in the ovarian tumors compared to effusions and solid metastases (p = 0.003).
|
30904337 |
2019 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression |
BEFREE |
The high expression of cancer stem cell transcription factors (Oct4, Sox2 and Nanog) is a valuable prognostic factor, suggesting a higher risk of tumor recurrence and metastasis.
|
29907293 |
2018 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
In specimens from patients with colorectal cancer, the expressions of cellular prion protein (PrP<sup>C</sup> ) and Oct4 were significantly correlated with metastasis and tumor stages.
|
30091203 |
2018 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression |
BEFREE |
Taken together, miR-299-3p regulated cell proliferation and metastasis by modulating the expression of OCT-4 and as such may prove to be an important therapeutic target.
|
29758200 |
2018 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
The correlation of OCT4, but not CD133, with the invasiveness of bladder cancer revealed that OCT4 can be considered as a key regulator of tumor progression, aggressive behavior, and metastasis; therefore, OCT4 can be a potential marker for targeted therapy of bladder cancer.
|
26945449 |
2017 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
The results suggest that (i) serumfree suspension cultivation is non-toxic and a convenient way for isolating the ECSCs, and is not limited to specific surface markers; (ii) Ishikawa cells can be used as an effective source of ECSCs, and the obtained ECSCs expressing the pluripotent stem cells markers CD44, CD133, Oct4, Sox2, and Nanog; (iii) ECSCs originated from Ishikawa cells showed an increased ability to invasion and metastasis in vitro, and exhibited a high proliferative capacity and pluripotency in vivo and vitro.
|
28625923 |
2017 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression |
BEFREE |
The findings suggest that identification of CTCs by EMT markers as well as evaluation of OCT4 expression status by assessment of OCT4 expression in CTCs could serve as potential adjuncts for evaluating metastasis and prognosis in NSCLC patients.
|
28374320 |
2017 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression |
BEFREE |
Our findings provide evidence of a specific role for PML in regulating Oct4 levels in liver CSCs and highlight the clinical importance of arsenic for improving the efficacy of other chemotherapeutic agents and the prevention of post-operative HCC recurrence and metastasis.
|
27517564 |
2016 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression |
BEFREE |
POU5F1/Oct-4 expression levels in breast cancer tissues were significantly higher in both the SLN metastasis and non-SLN metastasis groups (P = 0.003 and P = 0.030, respectively).
|
26931354 |
2016 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
In contrast, the positive rate of OCT4 in patients with distant metastasis was 92%.
|
26125892 |
2015 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression |
BEFREE |
Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
|
26483189 |
2015 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
In conclusion, the present study indicated that Oct4 affected the cell biology of lung cancer cells in vitro through promoting lung cancer cell metastasis via EMT; in addition, the results suggested that the association and degradation of the β‑catenin/E‑cadherin complex was regulated by Oct4 during the process of EMT.
|
25420671 |
2015 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
To the best of our knowledge, the results of the present study demonstrated for the first time, that miR‑145 inhibited lung cancer cell metastasis and EMT via targeting the Oct4 mediated Wnt/β‑catenin signaling pathway.
|
25483817 |
2015 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression |
BEFREE |
In conclusion, our results reveal that miR-26b is downregulated in EOC, and directly targets KPNA2. miR-26b/KPNA2 axis suppresses tumor proliferation and metastasis through decreasing OCT4 expression, which is indicative of the important role of miR-26b/KPNA2/OCT4 axis in EOC carcinogenesis and progression.
|
26204489 |
2015 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
Taken together, these evidences suggest that miR-145 serves as a tumor suppressor which downregulates LCICs' cancer stem cell properties and EMT process by targeting Oct4, leading to the inhibition of tumor growth and metastasis.
|
24903381 |
2014 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
Our findings indicate that Oct-4 and Nanog positively regulate the EMT process, contributing to breast cancer metastasis.
|
25301732 |
2014 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
We evaluated the metastatic phenotype of OCT4-silenced SW620 cells using standard migration and invasion assays in vitro and the commonly used mouse model for experimental metastases in vivo.
|
23076549 |
2013 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
CD133(+)/CD44(+)/Oct4(+)/Nestin(+) stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer.
|
23036582 |
2013 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
Expression of Oct4 in tumorospheres might indicate the presence of a population of ECSCs and its expression in xenograft tumors suggests that Oct4 is also associated with tumor metastasis.
|
21547540 |
2011 |
|
POU5F1P4
|
Neoplasm Metastasis
|
0.100 |
Biomarker |
BEFREE |
In conclusion, silencing Oct4 promotes invasion and metastasis in breast cancer cells by inducing EMT.
|
21798248 |
2011 |